CDx Partnership Bears Fruit with New FDA-Approved Test

This is an interesting example.

– Drugs (dabrafenib and trametinib for advanced melanoma) commercialized by GSK
– Test (for BRAF mutations) developed and manufactured by bioMerieux

Link to article